Trustedge Capital Limited has submitted its monitoring agency report for the quarter ended December 31, 2025, demonstrating compliant utilization of its rights issue proceeds. The report, prepared by CARE Ratings Limited as the monitoring agency, confirms no material deviations from the original fund utilization plan disclosed in the offer document.

Rights Issue Details and Fund Deployment

The company successfully completed its rights issue during October 9-16, 2025, raising Rs. 26.99 crore through equity shares. The monitoring report shows substantial progress in fund utilization across all designated objects during the quarter.

Capital Base Augmentation and Business Expansion

The primary objective of augmenting the capital base received Rs. 19.25 crore utilization through loan disbursals. The company provided a declaration confirming no disbursals were made to related parties or group companies, maintaining compliance with regulatory requirements.

Under general corporate purposes, the company allocated Rs. 5.00 crore specifically for business expansion through loan disbursals, as approved by the Rights Issue Committee. This allocation aligns with the offer document provisions allowing board-approved purposes subject to applicable laws.

General Corporate Purpose Breakdown

The detailed utilization of Rs. 5.69 crore under general corporate purposes includes:

Unutilized Funds Management

The remaining Rs. 1.67 crore has been prudently deployed in financial instruments to generate returns while maintaining liquidity. The company placed Rs. 1.70 crore in a fixed deposit with Axis Bank earning 5.80% return, maturing on January 27, 2026. Additionally, Rs. 0.05 crore is maintained in the monitoring account with Axis Bank.

Regulatory Compliance and Timeline Adherence

CARE Ratings Limited confirmed no delays in implementation of stated objects, with all activities progressing as per the FY25-26 timeline mentioned in the offer document. Issue expenses were completed by November 2025, while capital augmentation and general corporate purposes remain ongoing as planned.

The monitoring agency noted that actual issue expenses of Rs. 0.43 crore exceeded the estimated Rs. 0.38 crore, with the excess Rs. 0.05 crore adjusted against general corporate purposes as permitted under the offer document terms. This adjustment represents standard practice and does not constitute a deviation from the disclosed utilization plan.

Trustedge Capital Limited has announced its unaudited standalone financial results for the quarter and nine months ended December 31, 2025, along with key corporate governance decisions. The Board of Directors approved these results at their meeting held on January 28, 2026, which commenced at 03:00 PM IST and concluded at 05:00 PM IST.

Financial Performance Overview

The company demonstrated strong quarterly performance with significant growth in revenue streams. Total revenue from operations reached ₹131.07 lakhs for Q3FY26, marking a substantial increase from ₹27.03 lakhs in the corresponding quarter of the previous year.

Revenue Composition and Growth

The company's revenue growth was primarily driven by interest income, which increased significantly to ₹115.99 lakhs in Q3FY26 from ₹26.22 lakhs in Q3FY25. Additionally, the company generated ₹12.23 lakhs from fees and commission during the quarter, compared to nil in the previous year. Net gain on fair value changes contributed ₹2.85 lakhs to the quarterly revenue.

Expense Management and Profitability

Total expenses for Q3FY26 stood at ₹121.92 lakhs, with employee benefits expense being the largest component at ₹97.28 lakhs. Other expenses accounted for ₹24.54 lakhs during the quarter. The company reported a profit before tax of ₹19.61 lakhs for Q3FY26, compared to ₹18.96 lakhs in the corresponding previous quarter.

Corporate Governance Updates

The Board re-appointed M/s MGP & Associates, Chartered Accountants (FRN: 140164W) as internal auditors for the financial year ending March 31, 2026. The firm, founded in 2014, provides comprehensive professional services including audit, tax advisory, management consultancy, and financial management across various industries.

Capital Structure and Share Allotment

During the current quarter, the company allotted 33,74,428 fully paid-up equity shares at an issue price of ₹80.00 per share, including share premium of ₹70.00 per share, aggregating to ₹2,699.54 lakhs on a rights basis. The paid-up equity share capital increased to ₹922.80 lakhs as of December 31, 2025, from ₹431.91 lakhs in the previous year.

Regulatory Compliance

The financial results have been prepared in accordance with Indian Accounting Standard 34 and comply with Regulation 33 of the SEBI Listing Regulations. The results were reviewed by the Audit Committee and subsequently approved by the Board of Directors. M/s Mahendra N. Shah & Co. Chartered Accountants (FRN:105775W) conducted a limited review of the standalone financial results as statutory auditors.